Basilea Pharmaceutica Unveils Promising Data on Novel Antifungal Drug Fosmanogepix at ESCMID Global 2025
"This is a game changer for treating serious fungal infections!"
"How does Fosmanogepix compare to existing treatments?"
"Invasive fungal infections are often overlooked in healthcare."
"I hope this brings hope to patients with resistant infections."
"The data sounds promising, but are there any side effects?"
"Great to see innovation in antifungal treatments!"
"Basilea is stepping up in the fight against fungal infections."
"I wonder how quickly these drugs can be made available?"
"Fungal infections are so often neglected; this is refreshing!"
"Let's hope for swift approval and availability for these treatments."
2025-04-16T05:15:00.000Z
Lars Andersen
Source of the news: www.globenewswire.com